Risk factor burden and control at the time of admission in patients with acute myocardial infarction

Results from the NCDR

Andre R M Paixao, Jonathan R. Enriquez, Tracy Y. Wang, Shuang Li, Jarett D Berry, Amit Khera, Sandeep R Das, James A de Lemos, Michael C. Kontos

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background Understanding risk factor burden and control as well as perceived risk prior to acute myocardial infarction (MI) presentation may identify gaps in contemporary systems of care. Methods Patients presenting with MI in the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry - Get With the Guidelines between January 2007 and November 2013 (N = 443,117) were stratified into 5 mutually exclusive risk categories: Framingham Risk Score (FRS) <10% 74,990 (16.9%), FRS 10% to 20% 90,429 (20.4%), FRS >20% 25,701 (5.8%), diabetes without cardiovascular disease (CVD) 67,779 (15.3%), and prior CVD 184,218 (41.6%). Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol (non-HDL-C) goals and statin eligibility were determined based on the Third Adult Treatment Panel. Results At presentation, 66.3% met the low-density lipoprotein cholesterol goal, 66.8% met the non-HDL-C goal, 63.7% were nonsmokers, and 65.1% of patients with prior CVD were on aspirin. Only 36.1% of patients met all assessed risk factor control metrics. Overall statin eligibility prior to MI was 60.8%, and 61.1% of statin-eligible patients reported statin use. Conclusion Risk factor control prior to MI was suboptimal, with the majority of individuals failing to meet at least 1 risk factor control metric. More effective system-based interventions are needed to promote adherence to prevention targets.

Original languageEnglish (US)
Pages (from-to)173-179.e1
JournalAmerican Heart Journal
Volume170
Issue number1
DOIs
StatePublished - Jul 1 2015

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Patient Admission
Myocardial Infarction
Cardiovascular Diseases
LDL Cholesterol
Registries
Aspirin
Guidelines
lipoprotein cholesterol
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Risk factor burden and control at the time of admission in patients with acute myocardial infarction : Results from the NCDR. / Paixao, Andre R M; Enriquez, Jonathan R.; Wang, Tracy Y.; Li, Shuang; Berry, Jarett D; Khera, Amit; Das, Sandeep R; de Lemos, James A; Kontos, Michael C.

In: American Heart Journal, Vol. 170, No. 1, 01.07.2015, p. 173-179.e1.

Research output: Contribution to journalArticle

@article{8914ea0b1c044321bee8df0d3c2c0fa4,
title = "Risk factor burden and control at the time of admission in patients with acute myocardial infarction: Results from the NCDR",
abstract = "Background Understanding risk factor burden and control as well as perceived risk prior to acute myocardial infarction (MI) presentation may identify gaps in contemporary systems of care. Methods Patients presenting with MI in the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry - Get With the Guidelines between January 2007 and November 2013 (N = 443,117) were stratified into 5 mutually exclusive risk categories: Framingham Risk Score (FRS) <10{\%} 74,990 (16.9{\%}), FRS 10{\%} to 20{\%} 90,429 (20.4{\%}), FRS >20{\%} 25,701 (5.8{\%}), diabetes without cardiovascular disease (CVD) 67,779 (15.3{\%}), and prior CVD 184,218 (41.6{\%}). Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol (non-HDL-C) goals and statin eligibility were determined based on the Third Adult Treatment Panel. Results At presentation, 66.3{\%} met the low-density lipoprotein cholesterol goal, 66.8{\%} met the non-HDL-C goal, 63.7{\%} were nonsmokers, and 65.1{\%} of patients with prior CVD were on aspirin. Only 36.1{\%} of patients met all assessed risk factor control metrics. Overall statin eligibility prior to MI was 60.8{\%}, and 61.1{\%} of statin-eligible patients reported statin use. Conclusion Risk factor control prior to MI was suboptimal, with the majority of individuals failing to meet at least 1 risk factor control metric. More effective system-based interventions are needed to promote adherence to prevention targets.",
author = "Paixao, {Andre R M} and Enriquez, {Jonathan R.} and Wang, {Tracy Y.} and Shuang Li and Berry, {Jarett D} and Amit Khera and Das, {Sandeep R} and {de Lemos}, {James A} and Kontos, {Michael C.}",
year = "2015",
month = "7",
day = "1",
doi = "10.1016/j.ahj.2015.04.021",
language = "English (US)",
volume = "170",
pages = "173--179.e1",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Risk factor burden and control at the time of admission in patients with acute myocardial infarction

T2 - Results from the NCDR

AU - Paixao, Andre R M

AU - Enriquez, Jonathan R.

AU - Wang, Tracy Y.

AU - Li, Shuang

AU - Berry, Jarett D

AU - Khera, Amit

AU - Das, Sandeep R

AU - de Lemos, James A

AU - Kontos, Michael C.

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Background Understanding risk factor burden and control as well as perceived risk prior to acute myocardial infarction (MI) presentation may identify gaps in contemporary systems of care. Methods Patients presenting with MI in the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry - Get With the Guidelines between January 2007 and November 2013 (N = 443,117) were stratified into 5 mutually exclusive risk categories: Framingham Risk Score (FRS) <10% 74,990 (16.9%), FRS 10% to 20% 90,429 (20.4%), FRS >20% 25,701 (5.8%), diabetes without cardiovascular disease (CVD) 67,779 (15.3%), and prior CVD 184,218 (41.6%). Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol (non-HDL-C) goals and statin eligibility were determined based on the Third Adult Treatment Panel. Results At presentation, 66.3% met the low-density lipoprotein cholesterol goal, 66.8% met the non-HDL-C goal, 63.7% were nonsmokers, and 65.1% of patients with prior CVD were on aspirin. Only 36.1% of patients met all assessed risk factor control metrics. Overall statin eligibility prior to MI was 60.8%, and 61.1% of statin-eligible patients reported statin use. Conclusion Risk factor control prior to MI was suboptimal, with the majority of individuals failing to meet at least 1 risk factor control metric. More effective system-based interventions are needed to promote adherence to prevention targets.

AB - Background Understanding risk factor burden and control as well as perceived risk prior to acute myocardial infarction (MI) presentation may identify gaps in contemporary systems of care. Methods Patients presenting with MI in the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry - Get With the Guidelines between January 2007 and November 2013 (N = 443,117) were stratified into 5 mutually exclusive risk categories: Framingham Risk Score (FRS) <10% 74,990 (16.9%), FRS 10% to 20% 90,429 (20.4%), FRS >20% 25,701 (5.8%), diabetes without cardiovascular disease (CVD) 67,779 (15.3%), and prior CVD 184,218 (41.6%). Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol (non-HDL-C) goals and statin eligibility were determined based on the Third Adult Treatment Panel. Results At presentation, 66.3% met the low-density lipoprotein cholesterol goal, 66.8% met the non-HDL-C goal, 63.7% were nonsmokers, and 65.1% of patients with prior CVD were on aspirin. Only 36.1% of patients met all assessed risk factor control metrics. Overall statin eligibility prior to MI was 60.8%, and 61.1% of statin-eligible patients reported statin use. Conclusion Risk factor control prior to MI was suboptimal, with the majority of individuals failing to meet at least 1 risk factor control metric. More effective system-based interventions are needed to promote adherence to prevention targets.

UR - http://www.scopus.com/inward/record.url?scp=84937191138&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937191138&partnerID=8YFLogxK

U2 - 10.1016/j.ahj.2015.04.021

DO - 10.1016/j.ahj.2015.04.021

M3 - Article

VL - 170

SP - 173-179.e1

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 1

ER -